Skip to content ↓

Resources: News

Categories:
All
Articles
Events
Industry Insights
News
Webinars
White Papers

Latest in News

Pfizer’s Former Head of Real World Data and Analytics, Marc Berger, to Lead SHYFT Product Advisory Board

Pfizer’s Former Head of Real World Data and Analytics, Marc Berger, to Lead SHYFT Product Advisory Board

Waltham, MA – September 12, 2017 – SHYFT Analytics, the leading analytics cloud for life sciences, today announced the addition of Marc Berger, MD to head its Real World Evidence Product Advisory Board. Dr. Berger, the former Vice President of Real World Data and Analytics at Pfizer, joins SHYFT to help…

SHYFT Announces Strategic Investment From Optum

SHYFT Announces Strategic Investment From Optum

Optum investment closes out $20 million Series B funding that includes McKesson and Medidata following SHYFT’s 80% growth in SaaS Subscriptions in 2016 Investment advances SHYFT’s health care cloud analytics platform in areas of Real World Evidence, Specialty Pharma, Oncology and Rare Disease Waltham, MA – March 29, 2017 – SHYFT…

SHYFT Analytics Appoints Joseph Tyers to Chief Revenue Officer

SHYFT Analytics Appoints Joseph Tyers to Chief Revenue Officer

Life Sciences Software Executive to Lead Commercial Team Waltham, MA – January 24, 2017 – SHYFT Analytics, the leader in Cloud Analytics Solutions for global life sciences, today announced that Joseph Tyers has been named Chief Revenue Officer. An industry veteran and former Senior Vice President of Sales, Value Management and Commercial…

Medidata and SHYFT Analytics Form Commercial Partnership

Medidata and SHYFT Analytics Form Commercial Partnership

Technology Leaders Join Forces to Bring Real World Evidence Data Analytics to Drug Development NEW YORK, N.Y. and WALTHAM, M.A. – September 6, 2016 – Medidata (NASDAQ: MDSO) and SHYFT Analytics (SHYFT) today announced a strategic commercial partnership to increase access to healthcare data analytics in clinical trials. The partnership will enable…

SHYFT Analytics Raises 12.5 Million in New Funding from Global Healthcare and Technology Leaders, led by McKesson Ventures and Medidata Solutions

SHYFT Analytics Raises 12.5 Million in New Funding from Global Healthcare and Technology Leaders, led by McKesson Ventures and Medidata Solutions

Strategic Investments to Accelerate Growth Fueled by Demand for Healthcare Analytics Waltham, MA – August 30, 2016 – SHYFT Analytics, a leader in cloud data and analytics for the global life sciences industry, today announced the company has secured an initial $12.5 million in Series B funding. SHYFT Management opted for an…

SHYFT Analytics Appoints Priya Sapra to Chief Product Officer

SHYFT Analytics Appoints Priya Sapra to Chief Product Officer

Life Sciences Analytics Industry Veteran will Drive Technology Innovation and Product Strategy for Customer Benefit Waltham, MA – June 7, 2016 – SHYFT Analytics, a leader in cloud-based data and analytics solutions for the global life sciences industry, today announced senior leader Priya Sapra has been named Chief Product Officer. As a…

SHYFT Doubles Customers and Employees in 2015

SHYFT Doubles Customers and Employees in 2015

Novel Specialty Analytics and Real World Evidence Solutions Drive 100% Growth to Finish a Breakout Year Waltham, MA – December 21, 2015 – In less than 20 months after raising its first round of growth capital, SHYFT Analytics, a leader in cloud data management and guided analytics for global life sciences, has grown…

SHYFT Analytics Showcased in Gartner’s Hype Cycle for Life Sciences

SHYFT Analytics Showcased in Gartner’s Hype Cycle for Life Sciences

Customer Analytics Reaching Early Mainstream Adoption Waltham, MA (September 9, 2015) – SHYFT Analytics, (Formerly Trinity Pharma Solutions), a leader in cloud-based data and guided analytics solutions for the global life sciences industry, today announced that it has been identified as a sample vendor in Gartner’s Hype Cycle for Life…

Taking the Long View: Real World Evidence

Taking the Long View: Real World Evidence

As the healthcare industry becomes more patient-centric, patient outcomes will emerge as the key performance measures across the clinical-commercial continuum.  In practice this will require companies to fully leverage real world evidence (RWE) data to understand the patient journey and accurately evaluate the total cost of care across the lifetime…

Top 5 Global Pharma Company Using SHYFT’s RWE to Drive Adoption across Clinical-Commercial Continuum

Top 5 Global Pharma Company Using SHYFT’s RWE to Drive Adoption across Clinical-Commercial Continuum

SHYFT Analytics Delivers Transformational Insights to Life Sciences with Next Generation Real World Evidence Analytics Platform Waltham, MA—July 29, 2015 — SHYFT Analytics, a leader in cloud-based data and guided analytics solutions for the global life sciences industry, today announced formal availability of its next generation …